UroGen Pharma Ltd.
UroGen Pharma Ltd. (URGN) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 207 transactions totaling $11.9M, demonstrating a bearish sentiment with -$10.3M in net insider flow. The most recent transaction on Jan 31, 2026 involved a transaction of 32,609 shares valued at $0.
URGN Insider Activity Summary
Who Is Buying URGN Stock?
No significant insider buying has been recorded for URGN in the recent period.
Who Is Selling URGN Stock?
No significant insider selling has been recorded for URGN in the recent period.
Is UroGen Pharma Ltd. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for URGN is bearish with an Insider Alignment Score of 7/100 and a net flow of -$10.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
URGN Frequently Asked Questions
Understanding URGN Insider Activity
Insider trading at UroGen Pharma Ltd. (URGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading URGN stock, having executed 207 transactions in the past 90 days. The most active insider is Jay Moorin (Executive), who has made 2 transactions totaling $8.5M.
Related Tools
Track UroGen Pharma Ltd. Insider Activity
Get notified when executives and directors at URGN file new Form 4 transactions